Anna Milton

512 total citations
10 papers, 60 citations indexed

About

Anna Milton is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, Anna Milton has authored 10 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 7 papers in Hematology and 4 papers in Genetics. Recurrent topics in Anna Milton's work include Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Anna Milton is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Anna Milton collaborates with scholars based in United States, Germany and Netherlands. Anna Milton's co-authors include David B. Konrad, Sophia Groh, Gunnar Schotta, Ignasi Forné, Gustavo P. de Almeida, Andreas Schmidt, Axel Imhof, Naval Daver, Juan J. Rivera and Marina Konopleva and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Anna Milton

9 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Milton United States 4 33 17 14 14 9 10 60
Ioannis Siavelis Sweden 3 58 1.8× 32 1.9× 9 0.6× 30 2.1× 4 0.4× 4 95
Hera Canaj Canada 3 84 2.5× 20 1.2× 22 1.6× 7 0.5× 12 1.3× 3 116
José Refugio Torres‐Nava Mexico 6 18 0.5× 22 1.3× 23 1.6× 14 1.0× 9 68
Martha Margarita Velázquez‐Aviña Mexico 3 13 0.4× 10 0.6× 10 0.7× 7 0.5× 1 0.1× 5 32
M Rovira Spain 4 30 0.9× 4 0.2× 16 1.1× 17 1.2× 9 1.0× 12 69
Eva A. Coenen Netherlands 5 25 0.8× 8 0.5× 10 0.7× 22 1.6× 6 42
Lynn Ratner United States 6 26 0.8× 5 0.3× 25 1.8× 6 0.4× 8 0.9× 8 68
Katharina L. Gössling Germany 4 21 0.6× 7 0.4× 11 0.8× 6 0.4× 5 41
Paulina Richter‐Pechańska Germany 3 26 0.8× 51 3.0× 26 1.9× 34 2.4× 7 83

Countries citing papers authored by Anna Milton

Since Specialization
Citations

This map shows the geographic impact of Anna Milton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Milton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Milton more than expected).

Fields of papers citing papers by Anna Milton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Milton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Milton. The network helps show where Anna Milton may publish in the future.

Co-authorship network of co-authors of Anna Milton

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Milton. A scholar is included among the top collaborators of Anna Milton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Milton. Anna Milton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Milton, Anna, Mercedes Álvarez, Dongqing Wu, et al.. (2025). A Highly Reactive Cysteine-Targeted Acrylophenone Chemical Probe That Enables Peptide/Protein Bioconjugation and Chemoproteomics Analysis. JACS Au. 5(12). 5908–5916.
2.
3.
Nasr, Lewis, Nicholas J. Short, Jayastu Senapati, et al.. (2023). Inotuzumab ozogamicin (INO) for the treatment of measurable residual disease (MRD) in patients with B-cell acute lymphoblastic leukemia (B-ALL): Results from a phase II study.. Journal of Clinical Oncology. 41(16_suppl). e19008–e19008. 2 indexed citations
4.
5.
6.
Senapati, Jayastu, Nicholas J. Short, Yesid Alvarado, et al.. (2022). A Phase II Study of Inotuzumab Ozogamicin for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia. Blood. 140(Supplement 1). 3253–3255. 5 indexed citations
7.
8.
Milton, Anna & David B. Konrad. (2022). Epithelial-mesenchymal transition and H2O2 signaling – a driver of disease progression and a vulnerability in cancers. Biological Chemistry. 403(4). 377–390. 8 indexed citations
9.
Groh, Sophia, Anna Milton, Gustavo P. de Almeida, et al.. (2021). Morc3 silences endogenous retroviruses by enabling Daxx-mediated histone H3.3 incorporation. Nature Communications. 12(1). 5996–5996. 33 indexed citations
10.
Short, Nicholas J., Hagop M. Kantarjian, Yesid Alvarado, et al.. (2021). A Phase II Study of Inotuzumab Ozogamicin for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 2299–2299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis Siavelis Breakdown of academic impact, for papers by Hera Canaj Breakdown of academic impact, for papers by José Refugio Torres‐Nava Breakdown of academic impact, for papers by Martha Margarita Velázquez‐Aviña Breakdown of academic impact, for papers by M Rovira Breakdown of academic impact, for papers by Eva A. Coenen Breakdown of academic impact, for papers by Lynn Ratner Breakdown of academic impact, for papers by Katharina L. Gössling Breakdown of academic impact, for papers by Paulina Richter‐Pechańska
Rankless by CCL
2026